Table 2.
Baseline factors associated with best-corrected visual acuity improvement at 1 year in patients with diabetic macular oedema under anti-vascular endothelial growth factor therapy.
| VA change at the 12th month | ||
|---|---|---|
| P-value | Coefficient | |
| Hypertension | 0.001 | 0.209 |
| Previous treatment | 0.031 | 0.136 |
| Baseline VA (LogMAR) | < 0.001 | − 0.337 |
| Baseline epiretinal membrane | 0.048 | 0.123 |
| Baseline subretinal fluid | 0.001 | − 0.209 |
| Baseline HRF in the outer retina | 0.037 | − 0.007 |
VA visual acuity, HRF hyperreflective foci.